Biogen

From WikiMD's WELLNESSPEDIA

Biogen is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.

History[edit]

Biogen was founded in 1978 by several prominent biologists, including Nobel Prize winners Walter Gilbert and Phillip Sharp. The company's name is a portmanteau of "biological" and "genetic".

Products and Services[edit]

Biogen's products are focused on treating diseases in the areas of neurology, immunology, and hematology. Some of their most well-known products include Tecfidera, Avonex, and Tysabri, which are used to treat multiple sclerosis, and Spinraza, which is used to treat spinal muscular atrophy.

Research and Development[edit]

Biogen has a robust research and development program, with a focus on neurology and neurodegenerative diseases. The company is also involved in the research and development of therapies for autoimmune diseases and hematology.

Controversies[edit]

Biogen has faced several controversies over the years, including lawsuits related to patent infringement and pricing of their products.

See Also[edit]

References[edit]


External Links[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Biogen&oldid=6615660"